Aug. 19 at 11:28 AM
$COHR
Recent Highlights & Earnings Overview
Q4 Fiscal 2025 Results (Reported August 14, 2025)
Adjusted EPS:
$1.00 vs. expected
$0.92
Revenue:
$1.53 B (a 16% YoY increase)
AI‑related networking segment: +39% YoY to
$945 M
Stock fell nearly 20%, driven by a weak revenue outlook and the sale of its defense laser business for
$400 M, which will reduce quarterly revenue by ~
$20 M going forward
Analyst Response
Bank of America’s Vivek Arya downgraded from Buy to Neutral, citing slowing growth and margin pressures, though he raised his price target from
$92 to
$105
Technical Indicators & Chart Patterns
IBD triggered three Sell signals due to share price dropping below key technical levels (e.g., 50-day MA) and breaking from a cup-with-handle pattern
However, Coherent’s 52-week Relative Strength (RS) Rating rose from 88 to 92, suggesting strong relative performance—but now extended beyond the ideal buy range, with potential for a pullback to better entry points like the 50-day MA
